[1] 中国营养学会膳食指南修订专家..妇幼人群指南修订专家工作组 《临床儿科杂志》2016.4.34(4):287-291
[2] WHO(2001),”Global strategy for infant and young child feeding,the optimal duration of exclusive breastfeeding” Geneva,World Health Organization.
[3] Hamajima, N., Hirose, K., Tajima, K., Rohan, T., Calle, E., Heath, C., Košmelj, K., Primic-Žakelj, M., Ravnihar, B. and Stare, J. (n.d.). Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease.
[4] 中国发展研究基金会 《中国母乳喂养影响因素调查报告》[R].北京:中国发展研究基金会,2019:1-57.
[5] Anna Ojo-Okunola,etal,Nutriennts,2018Nov3;10(11):1643
[6] deAndrés J, Jiménez E, Chico-Calero I, et al. Physiological translocation of lactic acid bacteria during pregnancy contributes to the composition of the milk microbiota in mice [J]. Nutrients, 2018, 10: 14.
[7] a.Fernandez L, Cardenas N, Arroyo R, et al. Prevention of infectious mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy [J].Clinical Infectious Diseases, 2016, 62 (5): 568-573.
b. Rodriguez JM, Jimenez E, Schlembach D, et al. Prevention of mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy and early lactation [C/OL]. Milan: World of Microbiome: Pregnancy, Birth & Infancy Conference, 2019[2020-04-13]. http://microbiome2019.kenes.com/pbi2019/Documents/WoMPBI9%20Abstracts.pdf c. 临床试验中摄入量为每日 109CFU 唾液乳杆菌 PS2.
[8] Patel, S.H., Vaidya, Y.H., Patel, R.J. et al. Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep 7, 7804 (2017).
[9] Tang L, Lee AH, Qiu L, Binns CW. Mastitis in Chinese breastfeeding mothers: a prospective cohort study. Breastfeed Med. 2014;9(1):35-38.
[10] L. salivarius PS2 has been granted patent for invention in Europe, patent number EP3084009B1, and patent for invention in China, patent number ZL201480076005.0, owned by Nutricia.